nominally significantP = 0.05
FFR-guided CR showed a nominally significant reduction in cardiac death (RR: 0.69, 95% CI: 0.48–0.99; P = 0.05), but the wide 95% PI (0.38–1.25) suggests this benefit may not generalize uniformly.
FFR-guided CR showed a nominally significant reduction in cardiac death (RR: 0.69, 95% CI: 0.48–0.99; P = 0.05), but the wide 95% PI (0.38–1.25) suggests this benefit may not generalize uniformly.